Search
+
    SEARCHED FOR:

    BROKERAGE FIRMS

    Vodafone Idea shares jump nearly 4% as SC to hear AGR case on August 30

    Vodafone Idea shares surged 3.6% after the Supreme Court set a date for hearing its curative petition in the AGR case on August 30. Global brokerage firm Citi predicts potential benefits of Rs 4-5 per share. The hearing challenges the 2019 ruling on payments owed to the government.

    Hot stocks: Brokerage view on Paytm, Vodafone Idea and Jana Small Finance Bank

    Brokerage firms UBS, Jefferies, Citi, and Investec have offered varied ratings on Indian stocks. UBS and Jefferies give Paytm neutral and hold ratings, citing regulatory progress. Citi maintains a buy call on Vodafone Idea. Investec starts coverage on Jana Small Finance Bank with a buy rating, expecting strong earnings growth.

    LTIMindtree shares rally nearly 4% on upgrade by Kotak, GST relief

    LTIMindtree shares rose 3.6% to Rs 5,950 after Kotak Institutional Equities upgraded the stock and raised its target price to Rs 6,200, citing recovery prospects and strong growth. The company also received a stay order on a Rs 378 crore GST notice.

    Hot stocks: Brokerage view on L&T Finance, IndiGo and Zydus Lifesciences

    Axis Capital has downgraded IndiGo from a buy rating to an add rating, though it has raised the target price to Rs 5,100 from Rs 4,700. The downgrade reflects limited upside potential, with Axis Capital highlighting supply-side issues and noting that further improvement may be constrained as load factors are already at an optimal level of 80%.

    Hot stocks: Brokerages on DMart, Indegene, Indus Towers, Tata Motors and ONGC

    JPMorgan has maintained an "Overweight" rating on Tata Motors with a target price of Rs 1,250. Although JLR experienced a 1% year-over-year decline in July 2024 retail sales, China inventories are well-managed, and US inventories and incentives remain stable.

    Hot stocks: Brokerage view on Reliance, Apollo Hospitals, Zydus Life and L&T

    Several brokerage firms provided ratings on notable companies. CLSA rated Reliance as Outperform with a Rs 3,300 target. Nomura downgraded Apollo Hospitals to Neutral, targeting Rs 6,856. Citi maintained a Sell rating on Zydus Life with a Rs 890 target. BofA issued a Buy rating on L&T at Rs 4,043, anticipating margin expansion.

    The Economic Times
    BACK TO TOP